1. Anner, B. M., The receptor function of the Na+,K+-activated adenosine triphosphatase system. Biochem. J.227 (1985) 1–11.
2. Argento, N. B., Hamilton, B. P., Valente, W. A., and Hamlyn, J. M., Increased circulating levels of a ouabain-like compound in hypothyroid hypertension. Abstr. of the 45 th Annual Conference of the Council for High Blood Pressure Research, Sept. 24–27, 1991, Chicago, Ill., Hypertension18 (1991) 425.
3. Bova, S., Blaustein, M. P., Ludens, J. H., Harris, D. W., DuCharme, D. W., and Hamlyn, J. M., Effects of an endogenous ouabain-like compound on heart and aorta. Hypertension17 (1991) 944–950.
4. Broude, N. E., Modyanov, N. N., Monastyrskaya, G. S., and Sverdlov, E. D., Advances in Na+,K+-ATPase studies: from protein to gene and back to protein. FEBS Lett.257 (1989) 1–9.
5. De Wardener, H. E., and MacGregor, G. A., The ‘natriuretic hormone’ and hypertension. Handb. Hypertension8 (1986) 658–669.